Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.14 CAD | 0.00% | +7.69% | +75.00% |
04-18 | Transcript : Kane Biotech Inc. - Special Call | |
04-15 | Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale | MT |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
All Other
100.0
%
| 0 | 5.9 % | 0 | 100.0 % | -4.95% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
93.1
%
| 1 | 55.5 % | 0 | 93.1 % | -90.63% |
Canada
6.9
%
| 1 | 44.5 % | 0 | 6.9 % | -99.13% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 01/06/16 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 04/09/17 |
Compliance Officer | - | 11/08/19 | |
Gregory Schultz
CTO | Chief Tech/Sci/R&D Officer | 73 | 04/04/22 |
John Coleman
BRD | Director/Board Member | - | 11-15 |
Wendy Nachtigall
SAM | Sales & Marketing | - | 30/09/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 14/09/10 |
Chairman | 59 | 02-19 | |
Georges Morin
BRD | Director/Board Member | - | 19/05/20 |
Marc Edwards
CEO | Chief Executive Officer | - | 01/06/16 |
John Coleman
BRD | Director/Board Member | - | 11-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 131,844,567 | 85,786,381 ( 65.07 %) | 0 | 65.07 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+75.00% | 13.51M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- KNE Stock
- Company Kane Biotech Inc.